ViaDerma, Inc. (OTCMKTS:VDRM) Short Interest Up 1,287.5% in December
by Tristan Rich · The Markets DailyViaDerma, Inc. (OTCMKTS:VDRM – Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 11,100 shares, a growth of 1,287.5% from the November 30th total of 800 shares. Based on an average trading volume of 3,981,600 shares, the short-interest ratio is presently 0.0 days.
ViaDerma Stock Down 3.7 %
VDRM traded down $0.00 during trading on Thursday, hitting $0.01. 420,499 shares of the stock traded hands, compared to its average volume of 1,735,952. The business has a 50 day moving average price of $0.01 and a 200 day moving average price of $0.01. ViaDerma has a twelve month low of $0.00 and a twelve month high of $0.02.
ViaDerma Company Profile
ViaDerma, Inc operates as a specialty pharmaceutical company in the United States. It focuses on developing and marketing pharmaceutical products, as well as licensing its technology to companies in the pharmaceutical industry in various therapeutic areas. The company’s lead product is Vitastem, a tetracycline-based topical antibiotic used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Featured Articles
- Five stocks we like better than ViaDerma
- Learn Technical Analysis Skills to Master the Stock Market
- Top 3 Investment Themes to Watch for in 2025
- Expert Stock Trading Psychology Tips
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- How Can Investors Benefit From After-Hours Trading
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025